A transcranial magnetoacoustic coupled electrostimulation device and method with controllable magnetic field
By using Helmholtz coil and ultrasonic probe in a magnetic acoustic coupled electrical stimulation device, stepless adjustment of the magnetic field is achieved, and combined with the photoelectric signal acquisition component, the problem of insufficient flexibility caused by magnetic field fixation in the prior art is solved, and the problem of insufficient flexibility in the existing technology is realized. More precise neural regulation and efficient research results.
Patent Information
- Application Number
- CN202110981703.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-08-25
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2041-08-25
AI Technical Summary
The existing magnetic acoustic coupled electrical stimulation device has a fixed magnetic field size and is difficult to adjust, which limits the flexibility and depth of neural regulation.
Design a transcranial magnetic acoustic coupled electrical stimulation device with controllable magnetic field. Using Helmholtz coil and ultrasonic probe, the DC magnetic field, AC magnetic field and mixed magnetic field are generated by changing the current output of the power supply to achieve the absence of magnetic field. and combine the photoelectric signal acquisition component to collect and analyze local field potential signals and fluorescent signals to achieve precise neural regulation.
It realizes flexible regulation of magnetic fields, expands the research scope of neural regulation, improves the accuracy and effectiveness of experimental data, reduces experimental errors, and provides more accurate neural regulation methods.
Smart Images

Figure CN113679947B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of neural regulation technology, and specifically relates to a transcranial magnetoacoustic coupling electrical stimulation device and method with controllable magnetic field. Background Art
[0002] Neuropsychiatric diseases have become an important factor affecting people's quality of life. Currently, commonly used neuromodulation methods are divided into two categories: invasive and non-invasive. Invasive methods mainly include deep brain stimulation, etc., which implant electrodes deep into the brain and perform neuromodulation through microcurrent stimulation to treat movement disorders. This method has surgical risks and a low safety factor. Non-invasive methods mainly use physical energy such as sound, light, and electromagnetics for neuromodulation, and do not require invasive surgery. Currently, commonly used non-invasive neuromodulation methods include transcranial magnetic stimulation, transcranial direct current stimulation, etc. This method has problems such as insufficient stimulation depth and low resolution.
[0003] Transcranial magnetoacoustic coupling electrical stimulation is a new non-invasive neuromodulation method with the advantages of high spatial resolution, non-invasiveness, and direct regulation of nerves, and has attracted more and more attention. The stimulation system introduces a magnetic field while stimulating ultrasound, so that the ions in the nerve tissue vibrate in the uniform magnetic field under the action of ultrasound and then under the action of the Lorentz force, and the positive and negative ions move in opposite directions, generating induced current and electric field, so as to achieve the purpose of neuromodulation in the corresponding brain area.
[0004] Most existing magnetoacoustic coupling electrical stimulation devices use permanent magnets to generate static magnetic fields. The magnetic field size is fixed and the magnetic field type is single. If the magnetic field size is changed, it is necessary to replace the permanent magnets of different models, which brings many inconveniences to the research.
[0005] The present invention proposes a transcranial magnetoacoustic coupling electrical stimulation device and method with controllable magnetic field. The device can adjust the magnetic field size and change the magnetic field properties as needed, generate a DC magnetic field, an AC magnetic field, an AC bias magnetic field and a mixed magnetic field, and realize stepless regulation of the magnetic field. Summary of the invention
[0006] In view of the deficiencies in the prior art, the technical problem that the present invention intends to solve is to provide a transcranial magnetoacoustic coupling electrical stimulation device and method with controllable magnetic field.
[0007] The technical solution adopted by the present invention to solve the technical problem is:
[0008] A transcranial magnetoacoustic coupling electrical stimulation device with controllable magnetic field comprises an ultrasonic probe, a magnetic field generating component and a signal acquisition component; the magnetic field generating component comprises an operating table and a Helmholtz coil; the device is characterized in that the Helmholtz coil is placed on the operating table and connected to a power supply; an object to be stimulated is placed on the operating table, the head of the object to be stimulated is located in the middle of the Helmholtz coil, the Helmholtz coil is energized to generate a magnetic field, and the size and type of the magnetic field are adjusted by changing the size and type of the power supply output current; the ultrasonic probe acts on the head of the object to be stimulated, and the photoelectric signal acquisition component is used to collect the fluorescence signal and local field potential signal of the object to be stimulated after being stimulated.
[0009] The device can generate a DC magnetic field, an AC magnetic field and a mixed magnetic field; when the power supply outputs DC power, the Helmholtz coil generates a uniform magnetic field; when the power supply outputs AC power, the Helmholtz coil generates an AC magnetic field; when the power supply outputs DC power and AC power alternately, the Helmholtz coil generates a mixed magnetic field of alternating DC and AC.
[0010] The photoelectric signal acquisition component includes a photoelectric signal electrode sheet, an electrical signal emission module, a laser emission module and a signal acquisition and processing module; the photoelectric signal electrode sheet is implanted in the brain of the object to be stimulated, and the photoelectric signal electrode sheet is provided with an electrode terminal and an optical fiber terminal, the electrode terminal is connected to the electrical signal collection module, and the optical fiber terminal is connected to the laser emission module; the signal acquisition and processing module acquires fluorescence signals and local field potential signals.
[0011] The photoelectric signal electrode sheet includes four electrode terminals arranged in an array, the center distance between adjacent electrode terminals is 300 μm, and the diameter of a single electrode terminal is 25 μm.
[0012] The ultrasonic probe is provided with an ultrasonic phased array, the number of array elements is 64, the array element width is 0.25 mm, the array element length is 14 mm, and the spacing between adjacent array elements is 0.3 mm.
[0013] The present invention also provides a transcranial magnetic-acoustic coupling electrical stimulation method with controllable magnetic field, which is characterized by comprising the following contents:
[0014] (1) implanting a marker into the brain of a subject to be stimulated, installing a photoelectric signal electrode sheet on the brain of the subject to be stimulated, and collecting fluorescence signals and local field potential signals without stimulation as control signals;
[0015] (2) Place the head of the subject to be regulated on the operating table, between the two electromagnets;
[0016] (3) applying an ultrasonic probe to the target brain area of the subject to be stimulated, connecting the magnetic field control circuit and the ultrasonic transmitting system, and performing ultrasonic and static magnetic field stimulation on the subject to be stimulated. The ultrasonic direction and the magnetic field direction are perpendicular to each other, and under the combined action of the ultrasonic and static magnetic fields, an induced current is generated in the neural tissue to stimulate the neural tissue;
[0017] (4) The photoelectric signal acquisition component collects the fluorescence signal and local field potential signal under magnetoacoustic-electric stimulation, analyzes the changes of the fluorescence signal and local field potential signal under magnetoacoustic-electric stimulation relative to the control signal, and achieves precise neural regulation of the stimulated object by changing the magnetic field intensity and ultrasonic fundamental frequency.
[0018] The analysis process of step (4) is:
[0019] 4-1. The collected local field potential signal is subjected to baseline drift removal, power frequency interference removal and filtering processing, and the phase of the local field potential signal collected by two electrode terminals on one diagonal line of the photoelectric signal electrode sheet is cross-frequency coupled to obtain the phase-to-phase coupling strength of the local field potential signal;
[0020] 4-2. Cross-frequency coupling is performed on the phase of the low frequency band and the amplitude of the high frequency band in the local field potential signal collected by the two electrode terminals on the other diagonal line of the photoelectric signal electrode sheet to obtain the phase-amplitude coupling strength of the local field potential signal;
[0021] 4-3. Perform phase and amplitude coupling on the collected fluorescence signal to obtain the fluorescence signal modulation index;
[0022] 4-4. Construct the control index C shown in formula (11):
[0023]
[0024] Wherein, MI represents the phase-amplitude coupling strength of the local field potential signal, SI represents the phase-phase coupling strength of the local field potential signal, MIF represents the fluorescence signal modulation index, and ΔF represents the intensity change rate of the fluorescence signal;
[0025] A control threshold C1 is set. When C<C1, the magnetic field strength or ultrasonic fundamental frequency is increased; when C>C1, the magnetic field strength or ultrasonic fundamental frequency is reduced, thereby achieving precise neural control on the stimulated object.
[0026] The specific process of step 4-2 is as follows:
[0027] The local field potential signal is recorded as the time series x(t), and the local field potential signals collected by the two electrode terminals on the other diagonal line of the photoelectric signal electrode sheet are processed by the least squares filter to obtain the low-frequency series x fP (t) and high frequency sequence x fA(t); According to equations (6) and (7), the low-frequency sequence x corresponding to one of the local field potential signals is extracted respectively. fP The phase sequence φ of (t) fP (t) and another high-frequency sequence x corresponding to the local field potential signal fA (t) the amplitude envelope sequence A fA (t);
[0028]
[0029]
[0030] Among them, f p 、f A are the phase and amplitude of the time series x(t), respectively; H represents the standardized entropy measure, expressed as:
[0031]
[0032] In formula (8), p j The expression is:
[0033]
[0034] In formula (9), <A fA >φ fp (j) represents the phase sequence φ fP (t) is divided into J intervals, and the average amplitude of the jth interval;
[0035] The expression of the phase-amplitude coupling strength MI of the local field potential signal is:
[0036]
[0037] When p j =1 / J, H has a maximum value H max .
[0038] Compared with the prior art, the present invention has the following beneficial effects:
[0039] 1. The device generates a magnetic field of any size through the Helmholtz coil, and changes the size and properties of the magnetic field by adjusting the size and direction of the power supply output current, thereby achieving stepless adjustment of the magnetic field. It has the advantages of convenience, speed, and safety, and overcomes the defect that the magnetic field size generated by permanent magnets is fixed. Different types of currents can be output by the power supply to generate DC magnetic fields, AC magnetic fields, bias magnetic fields, and mixed magnetic fields. The magnetic field types are rich, which expands the research scope of neural regulation.
[0040] 2. The ultrasonic probe is equipped with an ultrasonic phased array, which contains multiple array elements and can perform single-point or multi-point precise control of the designated area under different stimulation modes.
[0041] 3. The local field potential signal is subject to 50Hz power frequency interference. Although the calcium ion concentration in the neural tissue is not affected by the power frequency, it is easily affected by light intensity. The frequency of change in calcium ion concentration is consistent with the discharge frequency of the neural tissue, and the two signals can complement each other. Therefore, the simultaneous collection of local field potential signals and fluorescence signals in the same brain area can eliminate data errors caused by power frequency interference and light to the greatest extent, improve the validity and accuracy of experimental data, and minimize experimental errors.
[0042] 4. Changes in calcium ion concentration in local neural clusters are closely related to neural discharge activity and can reflect fluctuations in the metabolic energy of nerve cells. Combined with local field potential signals, it will help further study the mechanism of neural regulation and its biological effects.
[0043] 5. The control index expression proposed in the present invention integrates neural electrical signals and calcium ion signals, which can effectively and reasonably reflect the effect of magnetoacoustic coupling electrical stimulation and facilitate the adjustment of stimulation parameters. BRIEF DESCRIPTION OF THE DRAWINGS
[0044] Figure 1 It is a schematic diagram of the overall structure of the present invention;
[0045] Figure 2 It is a structural schematic diagram of the operating table of the present invention;
[0046] Figure 3 This is the principle diagram of the time reversal method;
[0047] Figure 4 A schematic diagram of the propagation of the excitation signal of each array element of the ultrasonic phased array to the preset focus;
[0048] In the figure, 1-ultrasound probe; 2-magnetic field generating component; 3-photoelectric signal acquisition component; 4-object to be stimulated; 5-power supply;
[0049] 201-operating table; 202-Helmholtz coil; 201-1, bottom plate; 201-2, partition plate;
[0050] 301 - photoelectric signal electrode sheet; 302 - electrical signal acquisition module; 303 - laser emission and acquisition module; 304 - signal acquisition and processing module. DETAILED DESCRIPTION
[0051] The technical solution of the present invention is further described in detail below in conjunction with the accompanying drawings and specific embodiments, but the protection scope of the present application is not limited thereto.
[0052] like Figure 1As shown, the present invention is a transcranial magnetic-acoustic coupling electrical stimulation device with controllable magnetic field (hereinafter referred to as the device), comprising an ultrasonic probe 1, a magnetic field generating component 2 and a signal acquisition component 3; the magnetic field generating component 2 comprises an operating table 201 and a Helmholtz coil 202;
[0053] The Helmholtz coil 202 is placed on the operating table 201 and connected to the power supply 5; the subject to be stimulated is placed on the operating table 201, and the head of the subject to be stimulated is located in the middle of the Helmholtz coil 202. The Helmholtz coil 202 is energized to generate a magnetic field, and the current size of the Helmholtz coil 202 is changed by changing the current size output by the power supply 5, thereby adjusting the magnetic field size, so as to achieve coverage of different brain regions of the subject to be stimulated by the magnetic field;
[0054] The ultrasonic probe 1 acts on the head of the subject to be stimulated. The ultrasonic probe 1 is connected to the ultrasonic transmitting system and can generate different ultrasonic sequences to focus on a specific brain area of the subject to be stimulated at a single point or multiple points to achieve precise control;
[0055] The photoelectric signal acquisition component 3 is used to acquire the fluorescence signal and the local field potential signal of the object to be stimulated after being stimulated.
[0056] The device can generate a DC magnetic field, an AC magnetic field and a mixed magnetic field; when the power supply 5 outputs DC power, the Helmholtz coil 202 generates a uniform magnetic field, and the magnitude of the magnetic field can be changed by adjusting the magnitude of the DC power; when the power supply 5 outputs AC power, the Helmholtz coil 202 generates an AC magnetic field, and the magnitude of the magnetic field can be changed by changing the output current; when the power supply 5 alternately outputs DC power and AC power, the Helmholtz coil 202 generates a mixed magnetic field of alternating DC and AC.
[0057] The photoelectric signal acquisition component 3 includes a photoelectric signal electrode sheet 301, an electrical signal acquisition module 302, a laser emission and acquisition module 303 and a signal acquisition and processing module 304; the photoelectric signal electrode sheet 301 is implanted in the brain of the object to be stimulated, and an electrode terminal and an optical fiber terminal are provided on the photoelectric signal electrode sheet 301, the electrode terminal is connected to the electrical signal acquisition module 302 through a wire, and the optical fiber terminal is connected to the laser emission module and acquisition 303 through a wire; the ultrasound sequence generated by the ultrasound probe 1 is transmitted to the specific brain area of the object to be stimulated through the ultrasound probe, and the local field potential signal in the neural tissue of the object to be stimulated is transmitted to the signal acquisition and processing module 304 through the electrode terminal; the laser emitted by the laser emission and acquisition module 303 is transmitted to the specific brain area of the object to be stimulated through the optical fiber terminal, and the fluorescent signal in the neural tissue of the object to be stimulated is reversely transmitted to the signal acquisition and processing module 304 through the optical fiber terminal; the fluorescent marker is expressed for a period of time and can effectively combine with calcium ions in nerve cells, and laser irradiation can cause them to emit fluorescence. When nerve cells are stimulated differently, the fluorescence changes differently. The change in the intensity of the fluorescence signal reflects the change in the concentration of calcium ions in the nerve tissue, characterizing the activity of the nerve tissue and the degree of energy metabolism of nerve cells.
[0058] The photoelectric signal electrode sheet 301 includes four electrode terminals arranged in an array, which are used to collect local field potential signals of neural tissue clusters; the center distance between adjacent electrode terminals is 300μm, the diameter of a single electrode terminal is 25μm, and the number of optical fiber terminals can be set as needed. The diameter of a single optical fiber terminal is 200μm, which can collect fluorescence signals within a range of 300-500μm around the optical fiber terminal.
[0059] like Figure 2 As shown, the operating table 201 includes a base plate 201-1 and two partition plates 201-2 installed on the base plate 201-1 and facing each other. The base plate 201-1 is provided with two grooves for installing the Helmholtz coils 202. The partition plates 201-2 are used to axially limit the two Helmholtz coils 202 to prevent the two Helmholtz coils 202 from being attracted to each other after being energized.
[0060] The diameter of the Helmholtz coil 202 is 60 mm, the turn pitch is 0.1 mm, the number of turns is 500, and the diameter of the wire constituting the Helmholtz coil 202 is 1 mm.
[0061] The ultrasonic probe 1 is provided with an ultrasonic phased array, with 64 array elements, an array element width of 0.25 mm, an array element length of 14 mm, an array element spacing of 0.3 mm, a total phased length of 18.9 mm, and a fundamental frequency of each array element of 1 MHz; the ultrasonic phased array can achieve single-point or multi-point focusing.
[0062] The working principle and workflow of the present invention are:
[0063] The principle of Helmholtz coil: a pair of circular coils with the same number of turns, the same winding method and the same size are placed coaxially and current is passed through them in the same direction. When the distance between the two coils is equal to the radius of the circular coil, this combination is called a Helmholtz coil. According to the Biot-Savart law, the current element The magnetic induction intensity generated at any point in space for:
[0064]
[0065] Where μ0 is the vacuum magnetic permeability, N is the number of turns of the circular coil, and r is the distance from the current element to the space point; the magnetic induction intensity on the axis of the Helmholtz coil with a radius of R is:
[0066]
[0067] Where I is the current on the circular coil, and x is the position of the spatial point;
[0068] Transcranial magnetoacoustic coupling electrical stimulation combines static magnetic field and ultrasound to stimulate the organism. Since biological tissue contains charged ions, the charged ions in the biological tissue will be displaced by ultrasonic vibration after the application of ultrasound. Under the action of static magnetic field, these charged ions will be deflected by the Lorentz force, thereby generating induced current. Through the action of induced current, the activity of neural tissue is affected, its discharge rhythm is changed, and the effective regulation of the nervous system of the stimulated object is achieved. The induced current I ext It can be expressed as:
[0069]
[0070] Where σ represents tissue conductivity, B0 represents magnetic induction intensity, ρ represents tissue density, c0 represents ultrasonic propagation velocity, I u represents the ultrasonic intensity, f represents the ultrasonic fundamental frequency, and t represents the time independent variable.
[0071] like Figure 3 As shown in FIG, the time reversal method is used to focus the sound beam, a virtual point source is set at the preset focus, and each array element of the ultrasonic phased array receives the sound wave. According to the last-come-first-served principle, the cross-correlation algorithm is used to calculate the delay time of each array element when transmitting, so that the excitation signal of each array element can be accurately focused at the preset focus; Figure 4 As shown, the transmission time of each array element excitation signal is controlled according to the delay time of each array element transmission. Assuming that the signal received by the nth array element is X n (t), the corresponding signal after inversion in the time domain is X n(Tt); Redefine the signal of this array element as X n' (t), add a time constant t0 to each inversion signal, then the general formula of the time inversion signal of each array element is:
[0072]
[0073] Among them, K n is the compensation coefficient of each array element.
[0074] The excitation signal strength of each array element of the ultrasonic phased array is different. Generally, the weight of the array element at the center is greater than the weight of the array element at the edge, which can increase the main lobe energy, reduce the number of side lobes and suppress grating lobes.
[0075] Ultrasonic focusing methods include single-point focusing, multi-point focusing and regional focusing, which are conducive to precise control of the brain area to be stimulated; when single-point focusing is achieved, the array elements of the ultrasonic phased array do not need to be grouped, and the emission time of each array element can be precisely controlled to focus the excitation signal of each array element to the preset focus; when multi-point focusing is achieved, the array elements of the ultrasonic phased array need to be grouped, and the excitation signal of each group of array elements is controlled to focus at the preset focus; when regional focusing is achieved, the action angle and phase of each array element of the ultrasonic phased array emitting ultrasound are changed, so that the excitation signal of each array element is focused in the area where the preset focus is located. Ultrasonic stimulation modes include continuous stimulation, pulse stimulation and pulse cluster stimulation.
[0076] The magnetic field controllable transcranial magnetoacoustic coupling electrical stimulation method of the present invention comprises the following contents:
[0077] (1) Implanting a fluorescent marker into the brain of the subject to be stimulated, installing a photoelectric signal electrode sheet on the brain of the subject to be stimulated, and collecting the fluorescent signal and local field potential signal under no stimulation as a control signal;
[0078] (2) Place the head of the subject to be stimulated on the operating table, between the two Helmholtz coils;
[0079] (3) Connecting the magnetic field control circuit and the ultrasound transmitting system to perform ultrasound stimulation and static magnetic field stimulation on the target brain area of the subject to be stimulated. The ultrasound direction and the magnetic field direction are perpendicular to each other. Under the combined action of the ultrasound and static magnetic fields, an induced current is generated in the neural tissue to stimulate the neural tissue.
[0080] (4) Collect the fluorescence signal and local field potential signal of the target brain area under magnetoacoustic coupling electrical stimulation, analyze the changes of the fluorescence signal and local field potential signal under magnetoacoustic coupling electrical stimulation relative to the control signal, and achieve precise neural regulation of the stimulated object by changing the magnetic field intensity and ultrasonic fundamental frequency.
[0081] The analysis process of step (4) is:
[0082] 4-1. The collected local field potential signal is subjected to baseline drift removal, power frequency interference removal and filtering processing, and the phase of the local field potential signal collected by two electrode terminals on one diagonal line of the photoelectric signal electrode sheet is cross-frequency coupled using formula (5) to obtain the phase-phase coupling strength SI of the local field potential signal;
[0083]
[0084] Where m is the number of time points, i represents a complex number, is the phase value of the high-frequency band of the local field potential signal collected by one of the electrode terminals at time t, is the phase value of the low-frequency band of the local field potential signal collected by another electrode terminal at time t; the phase-phase coupling intensity SI of the local field potential signal is a complex number, and its magnitude is |SI|, which reflects the degree of phase synchronization. The value of |SI| is between 0 and 1, where 0 means that the phase is completely out of sync, and 1 means that the phase value is completely synchronized;
[0085] 4-2. The phase of the low frequency band and the amplitude of the high frequency band in the local field potential signal collected by the two electrode terminals on the other diagonal line of the photoelectric signal electrode sheet are cross-frequency coupled to obtain the phase-amplitude coupling strength of the local field potential signal, and the modulation index MI is used to characterize the phase-amplitude coupling strength of the local field potential signal;
[0086] The specific process is as follows: the local field potential signal is recorded as the time series x(t), and the local field potential signals collected by the two electrode terminals on the other diagonal are processed by the least squares filter to obtain the low-frequency series x fP (t) and high frequency sequence x fA (t); According to equations (6) and (7), the low-frequency sequence x corresponding to one of the local field potential signals is extracted respectively. fP The phase sequence φ of (t) fP (t) and another high-frequency sequence x corresponding to the local field potential signal fA (t) the amplitude envelope sequence A fA (t);
[0087]
[0088]
[0089] Among them, f p 、f A are the phase and amplitude of the time series x(t), respectively; H represents the standardized entropy measure, expressed as:
[0090]
[0091] In formula (8), p j The expression is:
[0092]
[0093] In formula (9), <A fA >φ fp (j) represents the phase sequence φ fP (t) is divided into J intervals, and the average amplitude of the jth interval;
[0094] In formula (8), when p j =1 / J, the maximum value of H is H max , the modulation index MI represented by the normalized entropy satisfies formula (10); the larger the modulation index MI, the greater the phase-amplitude coupling strength of the local field potential signal; the smaller the modulation index MI, the smaller the phase-amplitude coupling strength of the local field potential signal;
[0095]
[0096] 4-3. Couple the phase and amplitude of the collected fluorescence signal to obtain the fluorescence signal modulation index MIF;
[0097] 4-4. Construct the control index C shown in formula (11), and set the control threshold C1; when C<C1, increase the magnetic field strength or ultrasonic fundamental frequency; when C>C1, reduce the magnetic field strength or ultrasonic fundamental frequency, thereby achieving precise neural control on the stimulated object;
[0098]
[0099] In formula (11), ΔF represents the intensity change rate of the fluorescence signal, which is expressed as:
[0100] ΔF=(F-F0) / F0 (12)
[0101] Wherein, F represents the current fluorescence signal intensity, and F0 represents the baseline fluorescence signal intensity.
[0102] The above-mentioned embodiments are only descriptions of the preferred implementation methods of the present invention, and are not intended to limit the scope of the present invention. Without departing from the spirit of the invention, any simple modification or equivalent change of the above-mentioned embodiments based on the technical essence of the present invention shall fall within the protection scope of the present invention. Anything not described in the present invention shall apply to the prior art.
Claims
1. A transcranial magnetic acoustic coupling electrical stimulation device with controllable magnetic field, comprising an ultrasonic probe, a magnetic field generating component and a signal acquisition component; the magnetic field generating component comprises an operating table and a Helmholtz coil; characterized in that: The Helmholtz coil is placed on the operating table and connected to a power supply; the subject to be stimulated is placed on the operating table, the head of the subject to be stimulated is located in the middle of the Helmholtz coil, the Helmholtz coil is energized to generate a magnetic field, and the size and type of the magnetic field are adjusted by changing the size and type of the power supply output current; the ultrasonic probe acts on the head of the subject to be stimulated, and the photoelectric signal acquisition component is used to collect the fluorescence signal and local field potential signal of the subject to be stimulated after being stimulated; The collected local field potential signal is subjected to baseline drift removal, power frequency interference removal and filtering processing, and the phase of the local field potential signal collected by two electrode terminals on one diagonal line of the photoelectric signal electrode sheet is cross-frequency coupled to obtain the phase-phase coupling strength of the local field potential signal; The phase of the low frequency band and the amplitude of the high frequency band in the local field potential signal collected by the two electrode terminals on the other diagonal line of the photoelectric signal electrode sheet are cross-frequency coupled to obtain the phase-amplitude coupling strength of the local field potential signal; The collected fluorescence signal is phase-coupled with the amplitude to obtain the fluorescence signal modulation index; Construct the control index C shown in formula (11): Wherein, MI represents the phase-amplitude coupling strength of the local field potential signal, SI represents the phase-phase coupling strength of the local field potential signal, MIF represents the fluorescence signal modulation index, and ΔF represents the intensity change rate of the fluorescence signal; A control threshold C1 is set. When C<C1, the magnetic field strength or ultrasonic fundamental frequency is increased; when C>C1, the magnetic field strength or ultrasonic fundamental frequency is reduced, thereby achieving precise neural control on the stimulated object.
2. The magnetic field controllable transcranial magnetic acoustic coupling electrical stimulation device according to claim 1, characterized in that: The device can generate a DC magnetic field, an AC magnetic field and a mixed magnetic field; when the power supply outputs DC power, the Helmholtz coil generates a uniform magnetic field; when the power supply outputs AC power, the Helmholtz coil generates an AC magnetic field; when the power supply outputs DC power and AC power alternately, the Helmholtz coil generates a mixed magnetic field of alternating DC and AC.
3. The magnetic field controllable transcranial magnetic-acoustic coupling electrical stimulation device according to claim 1, characterized in that: The photoelectric signal acquisition component includes a photoelectric signal electrode sheet, an electrical signal emission module, a laser emission module and a signal acquisition and processing module; the photoelectric signal electrode sheet is implanted in the brain of the object to be stimulated, and the photoelectric signal electrode sheet is provided with an electrode terminal and an optical fiber terminal, the electrode terminal is connected to the electrical signal collection module, and the optical fiber terminal is connected to the laser emission module; the signal acquisition and processing module acquires fluorescence signals and local field potential signals.
4. The magnetic field controllable transcranial magnetic acoustic coupling electrical stimulation device according to claim 3, characterized in that: The photoelectric signal electrode sheet includes four electrode terminals arranged in an array, the center distance between adjacent electrode terminals is 300 μm, and the diameter of a single electrode terminal is 25 μm.
5. The transcranial magnetic-acoustic coupling electrical stimulation device with controllable magnetic field according to claim 1, characterized in that: The ultrasonic probe is provided with an ultrasonic phased array, the number of array elements is 64, the array element width is 0.25 mm, the array element length is 14 mm, and the spacing between adjacent array elements is 0.3 mm.
